Caribou Biosciences (CRBU) Income Statement: Revenue & Earnings

Caribou Biosciences Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Caribou Biosciences, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	9.99	34.48	13.85	9.60	12.36
Cost of Revenue	3.93	112.08	82.23	52.26	34.43
Gross Profit	6.07	34.48	-68.38	-42.66	-22.06
Operating Expenses
Research & Development	130.15	112.08	82.23	52.26	0.00
Selling, General & Administrative	46.46	38.46	38.02	24.32	14.06
Operating Expenses	172.68	150.54	120.25	76.58	14.06
Operating Income	-166.62	-116.06	-106.40	-66.98	-36.12
Other Income/Expense
Interest Income	0.00	15.30	0.00	0.15	0.24
Interest Expense	0.00	0.00	0.00	0.01	-0.02
Other Income/Expense	17.50	-15.47	7.05	0.38	0.51
Income
Income Before Tax	-149.11	-101.88	-99.35	-66.60	-36.13
Income Tax Expense	-0.01	0.19	0.07	0.32	-1.82
Net Income	-149.11	-102.07	-99.42	-66.92	-34.31
Net Income - Continuous Operations	-149.11	-102.07	-99.42	-66.92	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-162.69	-98.35	-104.78	-66.00	-35.22
EBIT	-149.11	-101.88	-106.40	-66.98	-36.12
Depreciation & Amortization	3.93	3.53	1.62	0.98	0.90
Earnings Per Share
Basic EPS	-2.00	-1.00	-2.00	-2.00	-4.00
Diluted EPS	-2.00	-1.00	-2.00	-2.00	-4.00
Basic Shares Outstanding	90.32	73.81	60.80	31.66	8.55
Diluted Shares Outstanding	90.32	73.81	60.80	31.66	8.55